Ali Behbahani Crispr Therapeutics Ag (CRSP) insider trading activity
Ali Behbahani is of CRISPR Therapeutics AG. Currently has a direct ownership of 256 shares of CRSP, which is worth approximately $12,902. The most recent transaction as insider was on Aug 13, 2020, when has been sold 57 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
256
0%
3M change
0%
12M change
Total Value Held
$12,902
Ali Behbahani Transaction History
Also insider at
AB
Ali Behbahani
Timonium, MD